Fennec Pharmaceuticals Inc. · NASDAQ:FENC

Evans Terry L received 168 Fennec Pharmaceuticals Inc. shares as an award (Form 4)

Traded Jul 31, 2026 · Filed Aug 3, 2026

On Jul 31, 2026, Evans Terry L (Chief Commercial Officer) received 168 Fennec Pharmaceuticals Inc. shares as an award, leaving 21,351 shares. Filed Aug 3, 2026 (Form 4).

Awarded
168 shares
Holding after
21,351 shares
Trading plan
No
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 31, 2026Common SharesAward16821,351Direct

Source

View original at SEC

Related